Skip to content
CancerIndex

Loading the knowledge graph…

A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia — knowledge graph · CancerIndex